Report Feature
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global cell banking outsourcing market report, please download the report brochure.
The study includes trends and forecast for the global cell banking outsourcing market by bank type, cell type, phase, and region as follows:
By Bank Type [Value ($ Million) shipment analysis for 2014 – 2025]:
- Master Cell Banking
- Working Cell Banking
- Viral Cell Banking
-
Stem Cell Banking
- Cord Stem Cell Banking
- Embryonic Stem Cell Banking
- Adult Stem Cell Banking
- Dental Stem Cell Banking
- IPS Stem Cell Banking
- Non-Stem Cell Banking
By Phase [Value ($ Million) shipment analysis for 2014 – 2025]:
- Bank Preparation
- Storage
- Characterization & Testing
- Safety Testing
- Viral
- Microbial Banks
- Gene Expression
- Karyology
- Gene Sequencing Testing
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Spain
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the cell banking outsourcing model companies profiled in this report include BioReliance, BioOutsource (Sartorious), BSL Bioservice, Cleancells, Charles River Laboratories, Covance, GlobalStem, Goodwin Biotechnology, Lonza, and Texcell.
Lucintel forecasts that master cell banking will remain the largest bank type segment over the forecast period due to longer duration of preservation of cells.
North America will remain the largest region over the forecast period due to a large number of pharmaceutical and biotechnology companies in the region, the presence of a well-established healthcare market, and rising production of vaccines, therapeutic proteins, and antibiotics.
|
Features of the Global Cell Banking Outsourcing Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global cell banking outsourcing market by bank type (master cell banking, working cell banking, and viral cell banking), cell type (stem cell banking (cord stem cell, embryonic stem cell, adult stem cell, dental stem cell, and IPS stem cell) and non-stem cell), phase (bank preparation, storage, characterization & testing, safety testing, viral, microbial banks, gene expression, karyology, and gene sequencing testing), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global cell banking outsourcing market? Q.5 What are the business risks and threats to the global cell banking outsourcing market? Q.6 What are the emerging trends in this cell banking outsourcing market and the reasons behind them? Q.7 What are some changing demands of customers in this cell banking outsourcing market? Q.8 What are the new developments in this cell banking outsourcing market? Which companies are leading these developments? Q.9 Who are the major players in this cell banking outsourcing market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this cell banking outsourcing market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global cell banking outsourcing market? |
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Bank Type (Master Cell Banking, Working Cell Banking, and Viral Cell Banking), Cell Type (Stem Cell Banking (Cord Stem Cell, Embryonic Stem Cell, Adult Stem Cell, Dental Stem Cell, and IPS Stem Cell) and Non-Stem Cell), and Phase (Bank Preparation, Storage, Characterization & Testing, Safety Testing, Viral, Microbial Banks, Gene Expression, Karyology, and Gene Sequencing Testing) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
Methodology
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.